Your browser doesn't support javascript.
loading
La utilidad del número necesario de pacientes a largo plazo a tratar para evaluar las terapias inhibidoras de las interleucinas 17 y 23 en el tratamiento de la psoriasis en placas de moderada a grave / The Utility of long-Term Number Needed to Treat to Evaluate Interleukin 17 and 23 Inhibitor Therapies in the Treatment of Moderate to Severe Plaque Psoriasis
González-Domínguez, A; García-Agua, N; Dauden, E; Ventayol-Bosch, P.
Affiliation
  • González-Domínguez, A; Weber. Madrid. España
  • García-Agua, N; Universidad de Málaga. Málaga. España
  • Dauden, E; Hospital Universitario La Princesa. Servicio de Dermatología. Instituto de Investigación Sanitaria de La Princesa. Madrid. España
  • Ventayol-Bosch, P; Hospital Universitario Son Espases. Servicio de Farmacia Hospitalaria. Palma de Mallorca. España
Actas dermo-sifiliogr. (Ed. impr.) ; 115(4): 427-429, Abr. 2024. tab
Article in Es | IBECS | ID: ibc-232027
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Patients / Psoriasis / Interleukin-17 / Interleukin-23 Limits: Female / Humans / Male Language: Es Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Patients / Psoriasis / Interleukin-17 / Interleukin-23 Limits: Female / Humans / Male Language: Es Journal: Actas dermo-sifiliogr. (Ed. impr.) Year: 2024 Document type: Article